AACR Names New Editor-in-Chief of the Journal Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of Christine A. Iacobuzio-Donahue, MD, PhD,...
Search/Filter
Loading...
Nobel Laureate Carolyn R. Bertozzi, PhD, to Receive 2023 AACR Award for Outstanding Achievement in Chemistry in Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) will honor Nobel Laureate Carolyn R. Bertozzi, PhD, with the...
AACR to Send 20 Early-career Researchers to Capitol Hill
WASHINGTON, D.C. – The American Association for Cancer Research (AACR) will host the eighth annual AACR Early-career Hill Day...
New Treatment Regimen May Decrease Mortality in Patients With Cardiotoxicity From Immune Checkpoint Inhibitors
Treatment consisted of high-dose abatacept, ruxolitinib, and proactive monitoring for respiratory muscle involvement PHILADELPHIA – Among cancer patients who...
Neoadjuvant Nivolumab Shows Long-term Benefit in Patients with Non-small Cell Lung Cancer
Study reports five-year survival outcomes PHILADELPHIA – Patients with resectable non-small cell lung cancer (NSCLC) who were treated with...
Carl H. June, MD, FAACR, Honored with 2023 AACR Award for Lifetime Achievement in Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) will award Carl H. June, MD, Fellow of the AACR...
Clonal Hematopoiesis May Be More Common Among Pediatric Cancer Survivors Than the General Population
Researchers identified mutational signatures characteristic of chemotherapy exposure PHILADELPHIA – Researchers identified a higher rate of clonal hematopoiesis (CH)...
AACR Statement on State of the Union Address
American Association for Cancer Research (AACR) President Lisa M. Coussens, PhD, FAACR, issued the following statement on President Biden’s...
AACR and AORTIC Announce Four Grants to Support Early-career Cancer Researchers in Africa
PHILADELPHIA — The American Association for Cancer Research (AACR) and the African Organisation for Research and Training in Cancer...
An Investigational T-cell Therapy Shows Promise Against Six Viral Infections Common After Stem Cell Transplants
Responses to the off-the-shelf therapy were observed in 95 percent of patients PHILADELPHIA – Posoleucel, an investigational allogeneic off-the-shelf...